Skip to main content

Care

By Dave Muoio | 04:04 pm | April 01, 2021
Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.
By Ahmed El Sherif | 01:18 pm | April 01, 2021
Hayat-Vax is a joint collaboration between Sinopharm CNBG and Abu Dhabi’s G42. Meanwhile, the country’s COVID-19 contact tracing app will now also function as a national vaccine registry.
By Dave Muoio | 12:11 pm | April 01, 2021
The virtual care startup will also look to accept additional health insurance carriers going forward.
By Dave Muoio | 03:51 pm | March 31, 2021
The company hopes to maintain its momentum after a year of substantial growth.
By Dave Muoio | 02:28 pm | March 31, 2021
The deal is valued at about $194 million and will drive about a third of the telemedicine company's expected revenue moving forward.
By Ahmed El Sherif | 08:04 am | March 31, 2021
Private bookings for a COVID-19 vaccine start from AED 1,300 (approx. $354).
By Sara Mageit | 10:47 am | March 30, 2021
The company's platform simplifies communication between patients and hospitals.
By Laura Lovett | 04:19 pm | March 29, 2021
According to FDA documents, the test is intended to help stop the spread of COVID-19 among Amazon employees. 
By Dave Muoio | 04:07 pm | March 29, 2021
The digital therapeutic for children's ADHD symptoms received a De Novo clearance last summer.
By Dave Muoio | 01:28 pm | March 29, 2021
The San Clemente, California-based company is aiming to expand its payer- and employer-focused care platform with the funds.